TFF Pharmaceuticals Q4 EPS $(2.01) Beats $(2.12) Estimate, Sales $114.33K Beat $100.00K Estimate
TFF Pharmaceuticals Q4 EPS $(2.01) Beats $(2.12) Estimate, Sales $114.33K Beat $100.00K Estimate
TFF Pharmicals第四季度每股收益美元（2.01美元）超過預期（2.12美元），銷售額114.33萬美元超過預期的100.00萬美元
TFF Pharmaceuticals (NASDAQ:TFFP) reported quarterly losses of $(2.01) per share which beat the analyst consensus estimate of $(2.12) by 5.19 percent. This is a 19.6 percent increase over losses of $(2.50) per share from the same period last year. The company reported quarterly sales of $114.33 thousand which beat the analyst consensus estimate of $100.00 thousand by 14.33 percent. This is a 63.45 percent decrease over sales of $312.78 thousand the same period last year.
TFF Pharmicals（納斯達克股票代碼：TFFP）公佈的季度虧損爲每股2.01美元（2.01美元），比分析師普遍預期的2.12美元（2.12美元）高出5.19％。這比去年同期每股虧損2.50美元（2.50）增長了19.6％。該公司公佈的季度銷售額爲114,330美元，比分析師普遍預期的10萬美元高出14.33％。這比去年同期的312,780美元的銷售額下降了63.45％。